Your browser doesn't support javascript.
loading
Assessment of the effect of erdafitinib on cardiac safety: analysis of ECGs and exposure-QTc in patients with advanced or refractory solid tumors.
Valade, Elodie; Dosne, Anne-Gaëlle; Xie, Hong; Kleiman, Robert; Li, Lilian Y; Perez-Ruixo, Juan José; Ouellet, Daniele.
Afiliación
  • Valade E; Janssen Research and Development, Turnhoutseweg 30, 2340, Beerse, Antwerp, Belgium.
  • Dosne AG; Janssen Research and Development, Turnhoutseweg 30, 2340, Beerse, Antwerp, Belgium. adosne@its.jnj.com.
  • Xie H; Janssen Research and Development, Spring House, PA, USA.
  • Kleiman R; eResearch Technology Inc. (ERT), Philadelphia, PA, USA.
  • Li LY; Janssen Research and Development, Spring House, PA, USA.
  • Perez-Ruixo JJ; Janssen Research and Development, Turnhoutseweg 30, 2340, Beerse, Antwerp, Belgium.
  • Ouellet D; Janssen Research and Development, Spring House, PA, USA.
Cancer Chemother Pharmacol ; 84(3): 621-633, 2019 09.
Article en En | MEDLINE | ID: mdl-31280362
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazoles / Quinoxalinas / Resistencia a Antineoplásicos / Corazón / Frecuencia Cardíaca / Neoplasias Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazoles / Quinoxalinas / Resistencia a Antineoplásicos / Corazón / Frecuencia Cardíaca / Neoplasias Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Bélgica